Zacks: Brokerages Anticipate The Coca-Cola Company (KO) Will Post Quarterly Sales of $7.42 Billion

Equities research analysts predict that The Coca-Cola Company (NYSE:KO) will report $7.42 billion in sales for the current fiscal quarter, Zacks Investment Research reports. Six analysts have made estimates for The Coca-Cola’s earnings, with the highest sales estimate coming in at $7.65 billion and the lowest estimate coming in at $7.27 billion. The Coca-Cola posted sales of $9.12 billion in the same quarter last year, which would indicate a negative year over year growth rate of 18.6%. The company is scheduled to announce its next earnings results before the market opens on Tuesday, April 24th.

On average, analysts expect that The Coca-Cola will report full-year sales of $7.42 billion for the current fiscal year, with estimates ranging from $31.43 billion to $32.09 billion. For the next fiscal year, analysts anticipate that the business will post sales of $32.98 billion per share, with estimates ranging from $32.08 billion to $33.42 billion. Zacks’ sales averages are an average based on a survey of sell-side research firms that follow The Coca-Cola.

How to Become a New Pot Stock Millionaire

The Coca-Cola (NYSE:KO) last released its earnings results on Friday, February 16th. The company reported $0.39 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.38 by $0.01. The Coca-Cola had a return on equity of 38.36% and a net margin of 3.52%. The business had revenue of $7.51 billion during the quarter, compared to the consensus estimate of $7.36 billion. During the same period last year, the business posted $0.37 earnings per share. The business’s revenue for the quarter was down 20.2% on a year-over-year basis.

A number of analysts have issued reports on the company. Goldman Sachs set a $49.00 target price on The Coca-Cola and gave the stock a “sell” rating in a research report on Wednesday, January 10th. Stifel Nicolaus reiterated a “hold” rating and issued a $49.00 price target on shares of The Coca-Cola in a research report on Friday, December 22nd. JPMorgan Chase reiterated a “neutral” rating and issued a price target (up from ) on shares of The Coca-Cola in a research report on Friday, February 16th. Credit Suisse Group reiterated a “buy” rating on shares of The Coca-Cola in a research report on Tuesday, February 13th. Finally, Jefferies Group reiterated a “neutral” rating and issued a $49.00 price target on shares of The Coca-Cola in a research report on Tuesday, February 20th. Two equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and twelve have given a buy rating to the company’s stock. The Coca-Cola presently has an average rating of “Hold” and a consensus price target of $49.21.

In other The Coca-Cola news, CFO Kathy N. Waller sold 23,240 shares of The Coca-Cola stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $46.15, for a total transaction of $1,072,526.00. Following the completion of the sale, the chief financial officer now owns 123,796 shares of the company’s stock, valued at $5,713,185.40. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Ed Hays sold 84,400 shares of The Coca-Cola stock in a transaction dated Tuesday, January 23rd. The stock was sold at an average price of $47.50, for a total value of $4,009,000.00. The disclosure for this sale can be found here. Insiders have sold 124,523 shares of company stock valued at $5,885,511 in the last three months. 1.48% of the stock is owned by corporate insiders.

Hedge funds have recently modified their holdings of the business. Amalgamated Bank lifted its stake in shares of The Coca-Cola by 54.8% in the 2nd quarter. Amalgamated Bank now owns 448,572 shares of the company’s stock valued at $20,118,000 after acquiring an additional 158,741 shares during the last quarter. Canada Pension Plan Investment Board increased its holdings in The Coca-Cola by 69.6% during the 3rd quarter. Canada Pension Plan Investment Board now owns 9,016,828 shares of the company’s stock valued at $405,847,000 after purchasing an additional 3,700,700 shares during the period. Calamos Advisors LLC increased its holdings in The Coca-Cola by 5.4% during the 3rd quarter. Calamos Advisors LLC now owns 1,660,216 shares of the company’s stock valued at $74,726,000 after purchasing an additional 84,539 shares during the period. Janney Montgomery Scott LLC increased its holdings in The Coca-Cola by 3.7% during the 3rd quarter. Janney Montgomery Scott LLC now owns 616,268 shares of the company’s stock valued at $27,738,000 after purchasing an additional 21,821 shares during the period. Finally, Manchester Capital Management LLC increased its holdings in The Coca-Cola by 19.9% during the 4th quarter. Manchester Capital Management LLC now owns 45,818 shares of the company’s stock valued at $2,102,000 after purchasing an additional 7,620 shares during the period. 66.15% of the stock is owned by hedge funds and other institutional investors.

NYSE:KO traded down $0.22 during trading hours on Tuesday, reaching $44.18. The stock had a trading volume of 2,864,234 shares, compared to its average volume of 13,388,771. The company has a debt-to-equity ratio of 1.64, a current ratio of 1.34 and a quick ratio of 1.25. The Coca-Cola has a 12-month low of $42.19 and a 12-month high of $48.62. The company has a market capitalization of $188,723.67, a P/E ratio of 23.15, a P/E/G ratio of 2.56 and a beta of 0.72.

The firm also recently disclosed a quarterly dividend, which was paid on Monday, April 2nd. Investors of record on Thursday, March 15th were paid a dividend of $0.39 per share. This is a positive change from The Coca-Cola’s previous quarterly dividend of $0.37. The ex-dividend date of this dividend was Wednesday, March 14th. This represents a $1.56 annualized dividend and a yield of 3.53%. The Coca-Cola’s dividend payout ratio (DPR) is currently 81.68%.

COPYRIGHT VIOLATION NOTICE: “Zacks: Brokerages Anticipate The Coca-Cola Company (KO) Will Post Quarterly Sales of $7.42 Billion” was first reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this news story on another domain, it was illegally copied and reposted in violation of U.S. and international copyright law. The legal version of this news story can be accessed at https://www.tickerreport.com/banking-finance/3335436/zacks-brokerages-anticipate-the-coca-cola-company-ko-will-post-quarterly-sales-of-7-42-billion.html.

The Coca-Cola Company Profile

The Coca-Cola Company, a beverage company, manufactures and distributes various nonalcoholic beverages worldwide. The company provides water, enhanced water, and sports drinks; juices; juice, dairy, and plant?based beverages; teas and coffees; and energy drinks. It also offers concentrates, syrups, beverage bases, source waters, and powders/minerals, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores.

Get a free copy of the Zacks research report on The Coca-Cola (KO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for The Coca-Cola (NYSE:KO)

Receive News & Ratings for The Coca-Cola Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Coca-Cola and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Pascal Coin  Hits Market Cap of $22.17 Million
Pascal Coin Hits Market Cap of $22.17 Million
Ormeus Coin  Reaches 1-Day Volume of $7.12 Million
Ormeus Coin Reaches 1-Day Volume of $7.12 Million
Cross Timbers Royalty Trust  Getting Somewhat Favorable News Coverage, Report Finds
Cross Timbers Royalty Trust Getting Somewhat Favorable News Coverage, Report Finds
Somewhat Favorable News Coverage Somewhat Unlikely to Affect MEI Pharma  Stock Price
Somewhat Favorable News Coverage Somewhat Unlikely to Affect MEI Pharma Stock Price
United-Guardian  Earning Somewhat Favorable Media Coverage, Study Shows
United-Guardian Earning Somewhat Favorable Media Coverage, Study Shows
Fresenius Medical Care  Given a €93.00 Price Target at Nord/LB
Fresenius Medical Care Given a €93.00 Price Target at Nord/LB


© 2006-2018 Ticker Report. Google+.